Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Urologic Diseases 1Nephritis 1Neoplasms 1Lymphoma, Non-Hodgkin 1Kidney Diseases 1Immune System Diseases 1Heart Failure 1Glomerulonephritis, IGA 1Glomerulonephritis 1Cardiomyopathies 1Autoimmune Diseases 1

Interventions

epicatechin gallate 1Valsartan 1Therapeutics 1Standard of Care 1Restraint, Physical 1Practice Guidelines as Topic 1Mesenchymal Stem Cell Transplantation 1Exercise 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cardiomyopathies × Valsartan × Clear all
NCT00162955 2012-05-08

Prevention of CHOP-induced Chronic Cardiotoxicity

Osaka City University

Phase 4 Completed
150 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Cardiomyopathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡